Cargando…

Case report: Percutaneous adrenal arterial embolization cures resistant hypertension

BACKGROUND: Primary aldosteronism is a common cause of resistant hypertension. Patients with primary aldosteronism due to aldosterone-producing adenoma are generally treated with unilateral adrenalectomy or medical therapy. Superselective adrenal arterial embolization is an alternative treatment for...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yaqiong, Wang, Dan, Liu, Qiting, Hou, Jixin, Wang, Peijian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592891/
https://www.ncbi.nlm.nih.gov/pubmed/36304542
http://dx.doi.org/10.3389/fcvm.2022.1013426
_version_ 1784815032384618496
author Zhou, Yaqiong
Wang, Dan
Liu, Qiting
Hou, Jixin
Wang, Peijian
author_facet Zhou, Yaqiong
Wang, Dan
Liu, Qiting
Hou, Jixin
Wang, Peijian
author_sort Zhou, Yaqiong
collection PubMed
description BACKGROUND: Primary aldosteronism is a common cause of resistant hypertension. Patients with primary aldosteronism due to aldosterone-producing adenoma are generally treated with unilateral adrenalectomy or medical therapy. Superselective adrenal arterial embolization is an alternative treatment for patients with unilateral primary aldosteronism. CASE SUMMARY: We present a 39-year-old male patient with a 5-year history of primary aldosteronism and secondary hypertension. The patient refused adrenalectomy while accepted pharmacotherapy. Despite taking adequate dose of spironolactone, the patient experienced repeatedly muscle weakness due to hypokalemia and had poor blood pressure control with left ventricular hypertrophy and renal dysfunction. Aldosterone-producing adenoma in the left adrenal gland was confirmed by computerized tomography and adrenal venous sampling. The left middle adrenal artery, which was confirmed to provide the main arterial supply to the aldosterone-producing adenoma, was embolized by injecting 2 ml ethanol. The embolization normalized his blood pressure for up to 3 months and reversed left ventricular hypertrophy. CONCLUSION: Superselective adrenal arterial embolization could be an alternative treatment for patients with aldosterone-producing adenoma who refuse adrenalectomy.
format Online
Article
Text
id pubmed-9592891
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95928912022-10-26 Case report: Percutaneous adrenal arterial embolization cures resistant hypertension Zhou, Yaqiong Wang, Dan Liu, Qiting Hou, Jixin Wang, Peijian Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: Primary aldosteronism is a common cause of resistant hypertension. Patients with primary aldosteronism due to aldosterone-producing adenoma are generally treated with unilateral adrenalectomy or medical therapy. Superselective adrenal arterial embolization is an alternative treatment for patients with unilateral primary aldosteronism. CASE SUMMARY: We present a 39-year-old male patient with a 5-year history of primary aldosteronism and secondary hypertension. The patient refused adrenalectomy while accepted pharmacotherapy. Despite taking adequate dose of spironolactone, the patient experienced repeatedly muscle weakness due to hypokalemia and had poor blood pressure control with left ventricular hypertrophy and renal dysfunction. Aldosterone-producing adenoma in the left adrenal gland was confirmed by computerized tomography and adrenal venous sampling. The left middle adrenal artery, which was confirmed to provide the main arterial supply to the aldosterone-producing adenoma, was embolized by injecting 2 ml ethanol. The embolization normalized his blood pressure for up to 3 months and reversed left ventricular hypertrophy. CONCLUSION: Superselective adrenal arterial embolization could be an alternative treatment for patients with aldosterone-producing adenoma who refuse adrenalectomy. Frontiers Media S.A. 2022-10-11 /pmc/articles/PMC9592891/ /pubmed/36304542 http://dx.doi.org/10.3389/fcvm.2022.1013426 Text en Copyright © 2022 Zhou, Wang, Liu, Hou and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Zhou, Yaqiong
Wang, Dan
Liu, Qiting
Hou, Jixin
Wang, Peijian
Case report: Percutaneous adrenal arterial embolization cures resistant hypertension
title Case report: Percutaneous adrenal arterial embolization cures resistant hypertension
title_full Case report: Percutaneous adrenal arterial embolization cures resistant hypertension
title_fullStr Case report: Percutaneous adrenal arterial embolization cures resistant hypertension
title_full_unstemmed Case report: Percutaneous adrenal arterial embolization cures resistant hypertension
title_short Case report: Percutaneous adrenal arterial embolization cures resistant hypertension
title_sort case report: percutaneous adrenal arterial embolization cures resistant hypertension
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592891/
https://www.ncbi.nlm.nih.gov/pubmed/36304542
http://dx.doi.org/10.3389/fcvm.2022.1013426
work_keys_str_mv AT zhouyaqiong casereportpercutaneousadrenalarterialembolizationcuresresistanthypertension
AT wangdan casereportpercutaneousadrenalarterialembolizationcuresresistanthypertension
AT liuqiting casereportpercutaneousadrenalarterialembolizationcuresresistanthypertension
AT houjixin casereportpercutaneousadrenalarterialembolizationcuresresistanthypertension
AT wangpeijian casereportpercutaneousadrenalarterialembolizationcuresresistanthypertension